Rehospitalization is not uncommon for the more than one million patients hospitalized annually with a primary diagnosis of heart failure.
At least half of patients are readmitted within 6 months of discharge; heart failure is the leading cause of hospitalization among adults over 65 years old in the U.S.
A new, free online CME course from the AOA and Impact Education walks physicians through the latest pharmacologic and patient care considerations for managing heart failure. The CME is approved for one AOA Category 1-B credit.
Opportunities for physicians
Physicians who treat patients with heart failure have the opportunity to reduce health care spending and improve outcomes by employing cutting-edge therapies to reduce hospital readmissions in heart failure patients.
Cardiovascular disease (CVD) is the leading cause of death in the U.S., claiming more than 647,000 lives annually, according to the CDC. Although it is not always identified as the definitive cause when someone dies from CVD, heart failure is often cited as an underlying cause of CVD deaths.
Recent trials covered
Presenters Carman A. Ciervo, DO, the chief physician executive at Jefferson Health, and Akshay S. Desai, MD, MPH, director of the heart failure disease management program at Brigham and Women’s Hospital, will review clinical practice guidelines for novel therapies in heart failure, including results from recent trials and evidence supporting averted heart failure-related hospitalizations and/or deaths.
They will also outline clinical scenarios for the appropriate prescribing of emerging heart failure therapies.
Complete this free CME course here.